Vorinostat Terminated Phase 1 / 2 Trials for Refractory Lymphomas / Relapsed Lymphomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs